FDA-cleared single-step immunoblot tests built on recombinant antigens from multiple Borrelia species detected nearly twice ...

A new peer-reviewed study published in the Journal of Clinical Microbiology finds that LymeSeek™, a single-tier Lyme disease ...

A peer-reviewed study reports ACES Diagnostics’ LymeSeek test achieved 90% sensitivity for early Lyme disease detection.

New research in PLOS Pathogens reveals that the Lyme disease spirochete actively produces the reactive metabolite ...

A new peer-reviewed study published in the Journal of Clinical Microbiology demonstrates the potential of LymeSeek™, a single-tier Lyme disease diagnostic test developed by ACES Diagnostics and its ...

Degrees Pharmaceuticals, a Washington, D.C.-based company developing medicines for vector-borne disease, announced on October ...

Drugmakers are pushing to develop effective defenses against Lyme disease as intensifying tick seasons continue to put more ...

After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recommended completing the study with the ...

Federal health agencies are investing nearly $3 million in experimental wildlife-based tick control methods aimed at reducing ...

Researchers at Hainan University showed that vaccinating rabbits with recombinant Mucin-6 from the tick Rhipicephalus linnaei ...

Once confined to the Southeast, aggressive lone star ticks have expanded across North America due to warming climates and growing deer populations. Their bites can transmit alpha-gal, a severe allergy ...

As an elite rugby player who has Type 1 diabetes, Henry Slade has grown accustomed to the demands of the condition ...